跳到正文
原文
Incyte· @Incyte · X·· 24 天前AI 评分38
AI 导读

我们宣布与@Genmab开展临床试验合作,针对携带KRAS G12D突变的一线转移性结直肠癌(CRC)患者。了解更多。https://bit.ly/4BpE07x

正文

We’ve announced a clinical trial collaboration with @Genmab for patients with first-line metastatic colorectal cancer (CRC) harboring a KRAS G12D mutation. Learn more. https://bit.ly/4BpE07x

来源:Incyte · x.com